PharVision Advisers’s McDonald's MCD Stock Holding History

PharVision Advisers’s Portfolio MCD Stock Details MCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,160	Closed	-$353K	–	882
2025 Q3	$353K	Buy	+1,160	New	+$353K	0.2%	138

Other funds holding MCD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

PharVision Advisers's MCD Position: Q4 2025 in Review

PharVision Advisers sold out of McDonald's (MCD) in Q4 2025, closing a stake of 1,160 shares — an estimated $353K sold.

PharVision Advisers first reported a position in MCD in Q3 2025 and held it in 1 quarter. The position peaked at $353K in Q3 2025. 3,566 funds tracked by Wall St. Rank hold MCD as of Q4 2025.

PharVision Advisers reported no remaining McDonald's position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 1,160 McDonald's shares in Q4 2025, an estimated $353K.
PharVision Advisers first reported a position in McDonald's in Q3 2025 and held it in 1 quarter.
PharVision Advisers's McDonald's position peaked at $353K in Q3 2025.
3,566 funds tracked by Wall St. Rank held McDonald's as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.